Evaluating Efficacy of Unani Formulation in Tinea

Phase 2

• Conditions: Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

• Registration Number: CTRI/2021/08/036043
• Lead Sponsor: ational Research Institute of Unani Medicine for Skin Disorders

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

The partcipants will be included in the study on the basis of the following criteria:

i. Participants with positive mycology (KOH positive)

ii. Circumscribed lesions having any of the

following signs and symptoms on trunk and inguinal region:

a. Presence of pruritus and burning

b. Presence of scales

c. Presence of central clearing

d. Erythematous papules

Exclusion Criteria

The partcipants will be excluded:

i. Co-morbid conditions of the participants

ii. Pregnant or Lactating Women

iii. Significant pulmonary/ cardiovascular/ hepatorenal dysfunction

iv. Known cases of Immuno-compromised states (HIV/ AIDS, etc.), malignancies

v. History of Hypersensitivity to Luliconazole

vi. Participants not willing to attend treatment schedule regularly

vii. Participants using the following medications:

a. Systemic antifungal within 15 days of baseline visit

b. Systemic corticosteroids within 15 days of baseline visit

Study & Design

• Study Type: Interventional
• Study Design: Not specified